- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 253/06 - 1,2,4-Triazines
Patent holdings for IPC class C07D 253/06
Total number of patents in this class: 128
10-year publication summary
|
10
|
12
|
14
|
12
|
12
|
4
|
4
|
7
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mitsubishi Tanabe Pharma Corporation | 579 |
9 |
| Bayer AG | 3319 |
6 |
| Takeda Pharmaceutical Company Limited | 2707 |
6 |
| Shionogi & Co., Ltd. | 860 |
6 |
| The Broad Institute, Inc. | 1790 |
5 |
| University of Greenwich | 71 |
5 |
| Bayer Cropscience AG | 2055 |
4 |
| Nippon Soda Co., Ltd. | 893 |
4 |
| Promega Corporation | 571 |
4 |
| F. Hoffmann-La Roche AG | 7932 |
2 |
| Hoffmann-La Roche Inc. | 3400 |
2 |
| BASF SE | 20874 |
2 |
| Merck Sharp & Dohme Corp. | 2200 |
2 |
| The Johns Hopkins University | 5651 |
2 |
| Afferent Pharmaceuticals, Inc. | 25 |
2 |
| Beijing Tide Pharmaceutical Co. Ltd. | 88 |
2 |
| Denali Therapeutics Inc. | 242 |
2 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
2 |
| Nankai University | 233 |
2 |
| Pharmacyclics, Inc. | 107 |
2 |
| Other owners | 57 |